Biomarkers of vascular disease linking inflammation to endothelial activation: Part II.

Atherosclerosis is regarded as a dynamic and progressive disease arising from the combination of endothelial dysfunction and inflammation.1–6 This article is the second in a 2-part series examining emerging markers of inflammation and endothelial cell activation. The first article7 provided a brief overview of the link between inflammation, endothelial dysfunction, and atherosclerosis and began the examination of emerging inflammatory mediators. This second article continues with an exploration of more novel markers for cardiovascular disease.